Status: Not yet recruiting
A Study of the Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)
This study will consist of two parts. Double blind Part A will assess the safety, tolerability, and pharmacokinetics of 7 days of dosing in healthy adults, while open label Part B will evaluate the safety, tolerability, and efficacy of a 2-week treatment course in adults with tinnitus.
Participants needed: 100
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Tortugas Neuroscience, Inc.Updated: Aug 20, 2026Locations: 1
Eligibility criteria
Healthy male or female adults aged 18 to 64 years (or 65 to 80 years for an elde... [+15]
Any clinically significant acute or chronic medical condition that, in the inves... [+20]